MedPath

Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD

Conditions
Facioscapulohumeral Muscular Dystrophy 1a
Interventions
Other: No intervention, observational
Registration Number
NCT02541292
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

Facioscapulohumeral muscular dystrophy (FSHD) is the second most common muscular dystrophy with approximately 500 patients in Denmark. It is characterized by weakness and wasting of the facial muscles, the muscles in the shoulder region and of the legs.

The primary aim of this study is to investigate possible links and order between inflammation and fat infiltration in the muscles in patients with FSHD.

Approximately 15 patients with FSHD will be recruited for repeated MRI-scans during a year where the inflammation and fat infiltration in the muscles can be quantified.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Confirmed FSHD
Exclusion Criteria
  • All contraindications for undergoing an MRI scan

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patient groupNo intervention, observationalPatients over 18 years old with confirmed FSHD (facioscapulohumeral muscular dystrophy).
Primary Outcome Measures
NameTimeMethod
Muscle inflammationOne MRI scan per subject (exam lasts approximately 60 min.)

MRI (t2 mapping) will be used to quantify the inflammation in skeletal muscle.

Muscle fat fractionOne MRI scan per subject (exam lasts approximately 60 min.)

The Dixon MRI will be used to quantify the fat fraction in skeletal muscle.

Secondary Outcome Measures
NameTimeMethod
Muscle strengthOne muscle strength test per subject (exam lasts approximately 60 min.)

Isokinetic muscle dynamometry will be used to measure muscle strength.

Trial Locations

Locations (1)

Copenhagen Neuromuscular Center

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath